Prodrugs of substituted amino heterobi- cycles which modulate the function of the vanilloid-1 receptor (VR1)

Details for Australian Patent Application No. 2005214134 (hide)

Owner Merck Sharp & Dohme Limited

Inventors Burkamp, Frank; Castro Pineiro, Jose Luis; Hollingworth, Gregory John

Agent Spruson & Ferguson

Pub. Number AU-A-2005214134

PCT Pub. Number WO2005/080391

Priority 0403819.6 20.02.04 GB

Filing date 16 February 2005

Wipo publication date 1 September 2005

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

20 July 2006 PCT application entered the National Phase

  PCT publication WO2005/080391 Priority application(s): WO2005/080391

29 January 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005214135-Desaturase enzymes

2005214132-Benzamide derivatives and their use as glucokinae activating agents